|
|
|
|
|
|
| Continues to be the Largest Traditional Chinese Medicine Clinics Chain in Hong Kong |
HONG KONG, Oct 22, 2015 - (ACN Newswire) - PuraPharm Corporation Limited ("PuraPharm" or the "Group") (Stock code: 1498) a leading Hong Kong-based Chinese medicine company engaged in the research and development, production, marketing and sale of Concentrated Chinese Medicine Granule ("CCMG") products marketed under its "Nong's" brand, has today announced the opening of its 20th Nong's clinic in Hong Kong, another remarkable milestone in the Group's development. The Group continues to be the largest Traditional Chinese Medicine ("TCM") clinic chain in Hong Kong.
 | | PuraPharm Opens Its 20th Nong's Clinic in Hong Kong |
The Group's TCM clinic business grows rapidly, opening the 20th Nong's clinic in Hong Kong. The Nong's clinics provide one-stop services including medical diagnostic and dispensary service of CCMG products. Compared to just three TCM clinics as at 30 June 2014, the number of clinics of the Group has been rapidly increased in about 1.5 years. The Group has a strong confidence about the future development of the business.
The expansion of the Nong's clinics provides a driving force to the growth of the Group's business and at the same time helps build a stronger brand recognition in Hong Kong. The fast expansion of the clinics underscores the customers' large demand of Chinese medicine and CCMGs with proven efficacy are gaining in popularity. As for the location strategy, PuraPharm chooses locations with high population and a lack of modernized Chinese medicine clinics in the neighborhood with a reasonable rental. This prudent strategy enables good performance of the clinics, in turn generates positive profit return to the Group and its registered TCM practitioner partners.
Mr. Chan Yu Ling, Abraham, Founder, Chairman, Chief Executive Officer and Executive Director of PuraPharm, said, "We are pleased to see the fast growth of Nong's clinics. The launching of the 20th clinic marks a remarkable milestone for the Group and further enhances our competitiveness within the CCMG product market in Hong Kong and China. Moving forward, the Group will continue to strengthen its leading position in the CCMG market in Hong Kong while further expanding the new sales channels by increasing the number of the clinics to 30 by the end of 2015, as what we promised in the prospectus. We will continue to develop Nong's clinics, aiming to create fruitful returns to shareholders."
Contact:
Strategic Financial Relations Limited
Heidi So +852 2864 4826 heidi.so@sprg.com.hk
Joanne Lam +852 2864 4816 joanne.lam@sprg.com.hk
Maggie Ng +852 2864 4883 maggie.ng@sprg.com.hk
www.sprg.com.hk
Topic: Press release summary
Source: PuraPharm Corporation Limited
Sectors: Daily News
https://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
|
|
